Hound Partners’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Hound Partners’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-1,336,259	Closed	-$231M	–	28
2015 Q1	$231M	Buy	+1,336,259	New	+$196M	5.1%	9

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Hound Partners's SLXP Position: Q2 2015 in Review

Hound Partners sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 1,336,259 shares — an estimated $231M sold.

Hound Partners first reported a position in SLXP in Q1 2015 and held it in 1 quarter. The position peaked at $231M in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

Hound Partners reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
Hound Partners sold 1,336,259 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $231M.
Hound Partners first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q1 2015 and held it in 1 quarter.
Hound Partners's SALIX PHARMACEUTICALS LTD DEL position peaked at $231M in Q1 2015.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Hound Partners's 13F filing for Q2 2015, filed 14 Aug 2015.